secwatch.observer — SEC 8-K summary
======================================

Issuer:     IGC Pharma, Inc. (IGC)
CIK:        0001326205
Form:       8-K
Filed at:   2022-01-18T23:59:59+00:00
Accession:  0001185185-22-000067
Event type: leadership
Sentiment:  positive
Materiality: 0.50
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

India Globalization Capital appoints former Congressman Jim Moran to board of directors
--------------------------------------------------------------------------------

- Appointed former Congressman Jim Moran as independent Class C director effective Jan 18, 2022.
- Moran served Virginia's 8th District for 24 years; was on Appropriations, Banking, and Budget committees.
- He received 150,000 RSUs: 50,000 vest immediately, remainder over 2 years.
- Press release highlights Moran's expertise and IGC's Phase 2/3 Alzheimer's trial for IGC-AD1.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522000067/0001185185-22-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326205/000118518522000067/indiaglob20220118_8k.htm
  HTML page:      https://secwatch.observer/filing/0001185185-22-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer